Mary Jane Raymond
Analyst · Morgan Stanley. Your line is now open
Thank you, Giovanni, and good morning. We close our year with a strong performance that demonstrates our experience in integrating acquisitions and picking our market spots very well. On a pro forma basis, our revenue grew 12% in the quarter compared to Q4 fiscal year 2019 and was flat for the entire year. The pro forma measurement gives the effect to the Finisar revenue that was present at the same period last year prior to the acquisition. Our non-GAAP gross margin was 42.3% and 38.3% for the year, nearly at or above the II-VI non-GAAP gross margin for fiscal year 2019. Our non-GAAP operating income margin was 16.7% for the quarter and 13.6% for the year. We delivered $160 million of free cash flow for fiscal year 2020, exceeding the original business case that assumed breakeven cash flow for the first year. We are tracking well against our target of $150 million in annual cost synergies within three years after the close of the transaction. The delivery of our synergies through June 30, or nine months into the first year is $50 million, and we still expect to reach $70 million or double the first 12 months estimate. During the quarter, our total revenue of $746 million was split 72% in communication, 9% in industrial, 6% in aerospace and defense, 6% in consumer, 4% in semiconductor capital equipment, and the rest is in other markets. For the year, the total revenue of $2.4 billion was split 67% in communications, 12% in industrial, 7% in aerospace and defense, 6% in consumer, 5% in semiconductor capital equipment, and the rest in other markets, we had no 10% customers. From a growth perspective in the quarter, sequentially communications grew 25% consumer grew 27%, life sciences grew 12%, aerospace and defense grew 5%, and semiconductor capital equipment grew 4% with the remainder of our end market being flat. Growth in the quarter came primarily from China, the U.S. and Japan. Geographically for the quarter, revenue was 48% in North America, 27% in China, 16% in Europe, 7% in Japan, and 2% for the rest of the world. Quarterly GAAP EPS was $0.53 and non-GAAP EPS was $1 18 with after tax non-GAAP adjustments of $67 million in total. The Q4 GAAP and non-GAAP EPS were significantly affected by a tax benefit for the final year end tax rate. We had $102 million diluted shares in the quarter, because the 2022 convertible debt was diluted in the quarter. For the full year of fiscal year 2020, the share count was $84.8 million, the weighted average of the shares outstanding for the full year. For the quarter, GAAP return on sales was 6.9% and non-GAAP return on sales was 15.8%. At the segment level, the non-GAAP operating margins were 17.2% for Photonics and 15.6% for Compound Semiconductors. Photonics benefited from operating efficiencies and a very rich mix, including nearly doubling its submarine pump sales again this quarter compared to the same quarter last year. Compound Semi also benefited from strong sales of 3D sensing arrays and demand for Datacom components. For operating expenses or OpEx, the total for the quarter was $235 million on a GAAP basis and $191 million on a non-GAAP basis compared to $154 million in the third quarter of fiscal year 2020, mostly due to incentive compensation. We expect our run rate depreciation to be $44 million to $48 million a quarter at the current fixed asset level for fiscal year 2021. The one-year measurement period for purchase accounting will conclude on September 23, 2020. Stock comp was $24 million in the quarter, and transaction expenses, including severance were $5.3 million. Stock comp for fiscal year 2021 is expected to be about $68 million for about $17 million a quarter. Though this value does vary with the stock price for some components. Our June 30 backlog was a remarkable $957 million consisting of $587 million in Photonics and $370 million in Compound Semiconductors. This compares with last year's consolidated backlog -- this compares with last quarter's consolidated backlog of $893 million with $580 million in Photonics and $375 million in Compound Semiconductors. The backlog contains orders that will ship over the next 12 months. Capital expenditures this quarter were $29 million. For the full year, CapEx was $137 million. For fiscal year 2021, we expect CapEx to be between $190 million and $240 million. The FX loss in the quarter was $6.3 million and $14.4 million for the year affected by the extreme fluctuations in currency during the January to June periods. Interest expense for the quarter was $25.5 million. The tax rate in the quarter was a 26% benefit, and for the full year it was a 5% expense. The explanation of the fiscal year 2020 tax rate is complex due to purchase accounting. The strong operating performance in Q4 improved the full year tax rate and the adjustment of the first nine months year to-date tax expense to the final fiscal year 2020 tax rate drove a large tax benefit in the fourth quarter. For next year, we expect the tax rate to be between 20% and 30%. Turning to our capital markets raise completed on July 2nd, the company raised a total of $920 million, and after all fees, the company retain proceeds of $882 million. Shortly after settlement, we paid off the balance of the term loan B of about $715 million [ph], taking our net debt leverage ratio on the basis of our credit facility to two times. The forward interest expense is expected to be about $60 million [ph] a quarter or about $64 million a year including the amortization of remaining fees. Q1 fiscal year 2021, will have a $24 million one-time non cash write-off for the bank fees incurred to raise the term loan B in September of 2019 or Q1 of last year. The share count to be used for fiscal year 2021 is 116 million shares. This assumes that our 2022 convert is dilutive, and the preferred equity is anti-dilutive. Thus, we include the 7.3 million shares for the 2022 convert, and we do not include the maximum 9.2 million shares for the preferred equity. In calculating the EPS, the $28 million of annual dividends that will be paid on the preferred equity are about $7 million per quarter, need to be deducted from the net income to arrive at the net income available to common shareholders. The preferred equity will be mandatorily converted to common shares in July of 2024. The conversion will be between 7.75 million and 9.3 million shares. The conversion price is $51.60 a share. At June 30 year end, prior to any effects of the capital markets transaction, our cash was $493 million, our availability on our revolver was $375 million, including outstanding letters of credit, and our net debt position was $1.9 billion. Our net debt leverage ratio on the basis of our credit facility was 3.3 times at June 30th. Regarding our announced intention to acquire as Ascatron as well as all of the outstanding interests of the owners of the parent company of an Innovion. As the press release says, we expect both of these to close by the calendar year end, if not sooner. Both of them are capability acquisitions, both adding IT and key process technology to expand our epitaxial wafer platform. The combined cash outlay for both is under $40 million. At close both will be consolidated into the Compound Semiconductors segment. Revenue is immaterial from both for fiscal year 2021. Today, our shares in Innovion are accounted for as an equity investment. Transaction fees for both are about $2 million. And we have included the $2 million estimate for transaction fees in our non-GAAP item for the first quarter ended September 30. Turning to the outlook. Revenue for the first quarter of fiscal year 2021, ending September 30, 2020, is $700 million to $750 million and the EPS on a non-GAAP basis is $0.45 to $0.60 per diluted share. This is at today's exchange rate and an estimated 25% tax rate. The non-GAAP items in EPS include $0.45, including the pre tax amount of $20 million in stock comp, $21 million in amortization, $23.6 million or $24 million in debt extinguishment costs, and $5 million in cost to facilitate the integration, including the transaction fees. The share count to be used is 116 million shares. The actual dollar amount of non-GAAP items, the tax rate and exchange rate are all subject to change. Before we go to the Q&A, as a reminder, our answers today may contain certain forecasts, from which our actual results may differ due to a whole variety of factors, including but not limited to changes in the product mix, customer orders, competition, changes in trade and tariff regulations, and general economic conditions. We would also ask that each firm limit its questions to one question and one follow up. Joelle, you may open the line for questions.